Background: Prostate cancer cells have very high PCA3 messenger RNA levels, which turns them into one of the new biomarkers for prostate cancer prognosis and diagnosis.
Objective: Our goal here is to develop a new aptasensor to detect PCA3 release by the cancer cell.
Methods: DNA hairpin containing PCA3 aptamer was thiolated, conjugated to methylene blue (MB) redox probe, and immobilized on gold electrode through self-assembly to detect label-free cancer cells.
Results: Our data have evidenced stable and sensitive sensors presenting a wide linear detection range (0-150ng/mL). In addition, monitoring PCA3 released by different types of prostate cells can provide in-depth knowledge about prostate cancer dynamics; therefore, it is a powerful platform for earlier clinical diagnostic. The released PCA3 can vary depending on the type of adopted prostate cells.
Conclusion: PCA3 release was monitored in a group of cells for 2 h; it showed significantly higher expression in both LNCaP and PC-3 cells. This strategy provides a unique and simple methodology to achieve more sensitive and specific PCA3 detection; thus, it emerged as a promising tool for early cost-effective diagnosis.
[http://dx.doi.org/10.1002/cncr.31337] [PMID: 29781117]
[http://dx.doi.org/10.1073/pnas.0804549105] [PMID: 18663219]
[http://dx.doi.org/10.1200/JCO.2013.52.8505] [PMID: 25385735]
[http://dx.doi.org/10.1111/j.1464-410X.2011.10584.x] [PMID: 21939492]
[http://dx.doi.org/10.1373/clinchem.2005.063289] [PMID: 16627561]
[http://dx.doi.org/10.1021/acsami.9b19180] [PMID: 31765118]
[http://dx.doi.org/10.1073/pnas.1507882112] [PMID: 26080435]
[http://dx.doi.org/10.1038/srep12090] [PMID: 26174796]